ABI Research\'s 5th annual Trend Report identifies the 53 key technology trends that will come to fruition—and the 48 that won\'t—in 2025

SK bioscience\'s first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025,with interim results expected by 2026.

SHANGHAI,Dec. 12,2024-- CureGene Pharmaceutical ("CureGene"),a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antivir

BEIJING,Dec. 12,2024-- Zhangzhou Pien Tze Huang Pharmaceutical Co.,Ltd.,a Fujian-based traditional Chinese medicine (TCM) company,has been striving to expand its overseas markets,enhancing the influen

YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme

Green Tech Innovations Take Center Stage in STEM Competition KUALA LUMPUR,Malaysia,Dec. 13,2024-- Team Terralnnovatorsfrom Johor,made up of three 15-year-old students,has been crowned the winner of th